(Date:12/3/2009)...re-FirstCall/ -- Inverness Medical Innovations, In...ividuals to take charge of their health at home th...anagement, has declared a dividend of $3.00 per sh...d Stock ( IMA-PB). The dividend will be paid in sh...l to the quotient of (a) $3.00 divided by (b) 97% ...
(Date:12/2/2009)...e/ -- Reportlinker.com announces that a new market..., Neurostimulation - A Global Market Perspectiv...rostimulation---A-Global-Market-Perspective.html ...thused by the growing base of aging population, an...as, Parkinson,s, and Alzheimer,s disease. Widespre...
(Date:12/2/2009)...wire-FirstCall/ -- Peregrine Pharmaceuticals, Inc....ient enrollment in a dose confirmation and dosimet... glioblastoma multiforme (GBM), the deadliest form... antibody linked to a radioisotope being developed...cifically targets cells at the center of brain tum...
(Date:12/2/2009)...ember 2 Gamida Cell announced toda...animal study) safety and,efficacy of a gene therap...nell Medical College and Gamida Cell. The product ... as Cooley,s Anemia. , Gamida Cell is dev...o,populations of stem/progenitor cells. The compa...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Rabbit Anti-Human Evi-1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
...s the basic components required for the developmen...inant mouse Dickkopf homolog-1 (Dkk-1) in cell cul...cient materials to run ELISAs on approximately fif...onditions are met: The assay is run as summarized...
pCDF-1 Expression System plus Competent Cells from Novagen
Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: